Have a personal or library account? Click to login
Serum tumor markers for screening and early diagnosis of ovarian cancer Cover

Serum tumor markers for screening and early diagnosis of ovarian cancer

Revista Romana de Medicina de Laborator
Volume 21 (2013): Issue 4 (December 2013)
By: Octavian Gabriel J. Olaru and  Cătălina Monica C. Pena  
Open Access
|Dec 2013

References

  1. 1. Guenther J, Stiles A, Champion JD The lived experience of ovarian cancer: a phenomenological approach. J Am Acad Nurse Pract. 2012; 24(10): 595-603.10.1111/j.1745-7599.2012.00732.x
    Search in Google Scholar
  2. 2. Gentry-Maharaj A, Menon U Screening for ovarian cancer in the general population. Best Practice & Research Clinical Obstetrics & Gynaecology. 2012; 26: 243-256.10.1016/j.bpobgyn.2011.11.006
    Search in Google Scholar
  3. 3. Zhang B, Cai FF, Zhong XY An overview of biomarkers for the ovarian cancer diagnosis. European Journal of Obstetrics and Gynecology. 2011; 158(2): 119-123.10.1016/j.ejogrb.2011.04.023
    Search in Google Scholar
  4. 4. Zang B, Barekati Z, Kohler C, Radpour R, Asadollahi R, Holzgreve W et al. Proteomics and Biomarkers for Ovarian Cancer Diagnosis, Annals of Clinical & Laboratory Science. 2010; 40(3): 218-225.
    Search in Google Scholar
  5. 5. O'Malley D, Azodi M, Makkenchery A, Tangir J, McAlpine J, Kelly M. Serum protein markers for early detection on ovarian cancer. PNAS 2005; 102: 7677-82.10.1073/pnas.0502178102
    Search in Google Scholar
  6. 6. Jacobs IJ, Skates SJ, MacDonald N, Menon V, Rosenthal AN, Davies AP et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 1999; 353: 1207-1210.10.1016/S0140-6736(98)10261-1
    Search in Google Scholar
  7. 7. Moore R G, Maclaughlan S Current clinical use of biomarkers for ovarian cancer. Current opinion in oncology. 09/2010; 22(5):492-7.10.1097/CCO.0b013e32833c335120613519
    Search in Google Scholar
  8. 8. Lu KH, Skates S, Bevers TB, Newland W, Moore RG, Leeds L et al. A prospective US ovarian cancer screening study using the risk of ovarian cancer algorithm (ROCA). J Clin Oncol. 2010; 28:[suppl; abstract 5003]10.1200/jco.2010.28.15_suppl.5003
    Search in Google Scholar
  9. 9. Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecologic Oncology. 2009;112: 40-46.10.1016/j.ygyno.2008.08.031359409418851871
    Search in Google Scholar
  10. 10. Mor G, Visintin I, Lai Y, Zhao H, Schwartz P, Rutherford T et al. Serum protein markers for early detection of ovarian cancer. Proc. Natl. Acad. Sci. U.S.A..May 2005; 102(21): 7677-7682.
    Search in Google Scholar
  11. 11. Jacob F, Meier M, Caduff R, Goldstein D, Pochechueva T, Hacker N et al. No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecol Oncol. 2011; 121: 487-491.10.1016/j.ygyno.2011.02.02221420727
    Search in Google Scholar
  12. 12. Moore RG, Miller C, DiSilvestro P, et al. Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass. Obstet Gynecol. 2011; 118(2):280-288.10.1097/AOG.0b013e318224fce2359411021775843
    Search in Google Scholar
  13. 13. ROMA™ (HE4 EIA + ARCHITECT CA 125 IITM) prescribing information. Fujirebio Diagnostics, Inc., 2011.
    Search in Google Scholar
  14. 14. Zhang Z, Bast RC, Yu Y, Li J, Sokoll LJ, Rai AJ et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. Aug 2004; 64(16): 5882-90.
    Search in Google Scholar
  15. 15. Zhang Z, Chan DW Cancer proteomics: In Pursuit of “True”Biomarker Discovery. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2283-2286.10.1158/1055-9965.EPI-05-077416214905
    Search in Google Scholar
  16. 16. Song J, Daniel W, ”Cancer proteomics”. Clinical proteomics. 12/2006; (1542-6416), 2(3): 129.10.1007/BF02752495
    Search in Google Scholar
  17. 17. Hellstrom I, Hellstrom KE SMRP and HE4 as Biomarkers for Ovarian Carcinoma When Used Alone and in Combination with CA125 and/or Each Other. Advances in Experimental Medicine and Biology. 2008;622:15-21.10.1007/978-0-387-68969-2_218546615
    Search in Google Scholar
  18. 18. Hellstrom I, Friedman E, Verch T, Yang Y, Korach J, Jaffar J et al. Antimesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients. Cancer Epidemiol Biomarkers Prev. 2008;17:1520-6.10.1158/1055-9965.EPI-08-003918559570
    Search in Google Scholar
  19. 19. Nosov V, Su F, Amneus M, Birrer M, Robins T, Kotlerman J et al. Validation of serum biomarkers for detection of early-stage ovarian cancer. Am J Obstet Gynecol. 2009; 200:63910.1016/j.ajog.2008.12.04219285648
    Search in Google Scholar
  20. 20. Dieplinger H, Ankerst DP, Burges A, Lenhard M, Lingenhel A, Fineder L et al. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1127-1133.10.1158/1055-9965.EPI-08-065319336561
    Search in Google Scholar
  21. 21. Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM et al. A Framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res. 2011; 4: 375-383.10.1158/1940-6207.CAPR-10-0193305737221372037
    Search in Google Scholar
  22. 22. Bast RC, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J et al. New tumor markers: CA125 beyound. Int J Gynecol Cancer. 2005; 15: 274-281.10.1111/j.1525-1438.2005.00441.x16343244
    Search in Google Scholar
  23. 23. Moore RG, Brown AK, Miller MC, Skates S, Allard WJ, Verch T et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol. 2008; 108: 402-408. 10.1016/j.ygyno.2007.10.01718061248
    Search in Google Scholar
DOI: https://doi.org/10.2478/rrlm-2013-0046 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 465 - 472
Published on: Dec 31, 2013
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
ovarian cancer,
early diagnosis,
serum biomarkers or serum tumor markers,
sensitivity,
specificity
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2013 Octavian Gabriel J. Olaru, Cătălina Monica C. Pena, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.

Volume 21 (2013): Issue 4 (December 2013)